Skip to content

Regulation of circadian disturbances to reduce vulnerability of chronic heart failure based on health theory Establishment of a cohort for specific diseases of chronic heart failure: a prospective non-interventional real-world study

Regulation of circadian disturbances to reduce vulnerability of chronic heart failure based on health theory Establishment of a cohort for specific diseases of chronic heart failure: a prospective non-interventional real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000704
Enrollment
Unknown
Registered
2024-11-13
Start date
2024-07-15
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Circadian Rhythm Sleep-Wake Disorders Group:This study is an observational study without intervention

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Discharge patients diagnosed with chronic heart failure; (2) Class NYHA II-IV; (3) Age: 18 years old with no gender limit; (4) The patient has certain language expression and understanding ability understand and voluntarily fill in the informed consent form cooperate with the completion of blood test and can complete the sleep log scale assessment

Exclusion criteria

Exclusion criteria: (1) The acute phase of myocardial infarction (2) Patients with serious non-cardiovascular diseases or diseases affecting the life expectancy of patients such as history of connective tissue diseases malignant tumors organ failure caused by various causes severe immune system diseases etc. or combined with severe primary diseases such as liver kidney and hematopoietic system acute infectious diseases or mental illness; (3) Patients can not cooperate with the completion of the scale evaluation and blood drawing test; (4) women in pregnancy; (5) Combined with severe liver insufficiency (ALT> 100U / L or AST> 100U / L) severe renal insufficiency (glomerular filtration rate 5.5 mmol/L) (6) Other conditions that the attending doctor or investigator considers inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Minnesota Living with Heart Failure Questionnaire;Heart rate variability;Sleep-wake rhythms;Frailty Index;Patients readmitted to the hospital within 180 days;Echocardiogram;Fried Frailty Phenotype Questionnaire;NT-proBNP;

Countries

China

Contacts

Public ContactLi Xiao

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

lixiao617@hotmail.com13793188075

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026